Cartesian Therapeutics, Inc. Investment Income, Net
Cartesian Therapeutics, Inc. (RNAC) reported Investment Income, Net of $1.55 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2025-11-06
- Cartesian Therapeutics, Inc. investment income, net for the quarter ending 2025-09-30 was $1.55M, a 39.84% decline year-over-year.
- Cartesian Therapeutics, Inc. investment income, net for the quarter ending 2025-06-30 was $1.75M, a 46.28% increase year-over-year.
- Cartesian Therapeutics, Inc. investment income, net for the quarter ending 2025-03-31 was $2.02M, a 73.11% increase year-over-year.
- Cartesian Therapeutics, Inc. investment income, net for the quarter ending 2024-09-30 was $2.57M, a 98.08% increase year-over-year.
- Cartesian Therapeutics, Inc. investment income, net for fiscal 2023 was $4.96M, a 139.46% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. investment income, net for fiscal 2022 was $2.07M, a 4611.36% increase from fiscal 2021.
- Cartesian Therapeutics, Inc. investment income, net for fiscal 2021 was $44.00K, a 83.08% decline from fiscal 2020.
- Cartesian Therapeutics, Inc. investment income, net for fiscal 2020 was $260.00K, a 68.82% decline from fiscal 2019.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.55M 10-Q · filed 2025-11-06 | $3.30M derived: sum of 2 quarters · filed 2025-11-06 | $5.31M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.75M 10-Q · filed 2025-08-07 | $3.76M 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $2.02M 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | $2.57M 10-Q · filed 2025-11-06 | $3.77M derived: sum of 2 quarters · filed 2025-11-06 | $4.93M 10-Q · filed 2025-11-06 | $5.87M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.20M 10-Q · filed 2025-08-07 | $2.36M 10-Q · filed 2025-08-07 | $3.30M derived: sum of 3 quarters · filed 2025-08-07 | $4.60M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.16M 10-Q · filed 2025-05-08 | $2.10M derived: sum of 2 quarters · filed 2025-05-08 | $3.40M derived: sum of 3 quarters · filed 2025-05-08 | $4.80M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.24M derived: sum of 2 quarters · filed 2024-11-07 | $3.63M derived: sum of 3 quarters · filed 2024-11-07 | $4.96M 10-K · filed 2024-03-07 |
| 2023-09-30 | $1.30M 10-Q · filed 2024-11-07 | $2.69M derived: sum of 2 quarters · filed 2024-11-07 | $4.02M 10-Q · filed 2024-11-07 | $5.17M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.39M 10-Q · filed 2024-08-08 | $2.73M 10-Q · filed 2024-08-08 | $3.87M derived: sum of 3 quarters · filed 2024-08-08 | $4.58M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.33M 10-Q · filed 2024-05-08 | $2.47M derived: sum of 2 quarters · filed 2024-05-08 | $3.18M derived: sum of 3 quarters · filed 2024-05-08 | $3.39M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.85M derived: sum of 2 quarters · filed 2024-03-07 | $2.06M derived: sum of 3 quarters · filed 2024-03-07 | $2.07M 10-K · filed 2024-03-07 |
| 2022-09-30 | $710.00K 10-Q · filed 2023-11-13 | $917.00K derived: sum of 2 quarters · filed 2023-11-13 | $932.00K 10-Q · filed 2023-11-13 | $941.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $207.00K 10-Q · filed 2023-08-17 | $222.00K 10-Q · filed 2023-08-17 | $231.00K derived: sum of 3 quarters · filed 2024-03-07 | $242.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $15.00K 10-Q · filed 2023-05-04 | $24.00K derived: sum of 2 quarters · filed 2024-03-07 | $35.00K derived: sum of 3 quarters · filed 2024-03-07 | $47.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $20.00K derived: sum of 2 quarters · filed 2024-03-07 | $32.00K derived: sum of 3 quarters · filed 2024-03-07 | $44.00K 10-K · filed 2024-03-07 |
| 2021-09-30 | $11.00K 10-Q · filed 2022-11-03 | $23.00K derived: sum of 2 quarters · filed 2022-11-03 | $35.00K 10-Q · filed 2022-11-03 | $38.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $12.00K 10-Q · filed 2022-08-08 | $24.00K 10-Q · filed 2022-08-08 | $27.00K derived: sum of 3 quarters · filed 2023-03-02 | $31.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-05 | $15.00K derived: sum of 2 quarters · filed 2023-03-02 | $19.00K derived: sum of 3 quarters · filed 2023-03-02 | $32.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $7.00K derived: sum of 2 quarters · filed 2023-03-02 | $20.00K derived: sum of 3 quarters · filed 2023-03-02 | $260.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-09 | $17.00K derived: sum of 2 quarters · filed 2021-11-09 | $257.00K 10-Q · filed 2021-11-09 | $384.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-12 | $253.00K 10-Q · filed 2021-08-12 | $380.00K derived: sum of 3 quarters · filed 2022-03-10 | $564.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $240.00K 10-Q · filed 2021-05-13 | $367.00K derived: sum of 2 quarters · filed 2022-03-10 | $551.00K derived: sum of 3 quarters · filed 2022-03-10 | $797.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $311.00K derived: sum of 2 quarters · filed 2022-03-10 | $557.00K derived: sum of 3 quarters · filed 2022-03-10 | $834.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $184.00K 10-Q · filed 2020-11-05 | $430.00K derived: sum of 2 quarters · filed 2020-11-05 | $707.00K 10-Q · filed 2020-11-05 | $928.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $246.00K 10-Q · filed 2020-08-06 | $523.00K 10-Q · filed 2020-08-06 | $744.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.04M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $277.00K 10-Q · filed 2020-05-07 | $498.00K derived: sum of 2 quarters · filed 2021-03-12 | $793.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.04M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $516.00K derived: sum of 2 quarters · filed 2021-03-12 | $762.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.05M 10-K · filed 2021-03-12 |
| 2018-09-30 | $295.00K 10-Q · filed 2019-11-08 | $541.00K derived: sum of 2 quarters · filed 2019-11-08 | $829.00K 10-Q · filed 2019-11-08 | $1.07M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $246.00K 10-Q · filed 2019-08-08 | $534.00K 10-Q · filed 2019-08-08 | $772.00K derived: sum of 3 quarters · filed 2020-03-12 | $937.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $288.00K 10-Q · filed 2019-05-09 | $526.00K derived: sum of 2 quarters · filed 2020-03-12 | $691.00K derived: sum of 3 quarters · filed 2020-03-12 | $792.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $403.00K derived: sum of 2 quarters · filed 2020-03-12 | $504.00K derived: sum of 3 quarters · filed 2020-03-12 | $617.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $165.00K 10-Q · filed 2018-11-08 | $266.00K derived: sum of 2 quarters · filed 2018-11-08 | $379.00K 10-Q · filed 2018-11-08 | $492.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $101.00K 10-Q · filed 2018-08-08 | $214.00K 10-Q · filed 2018-08-08 | $327.00K derived: sum of 3 quarters · filed 2019-03-15 | $425.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $113.00K 10-Q · filed 2018-05-09 | $226.00K derived: sum of 2 quarters · filed 2019-03-15 | $324.00K derived: sum of 3 quarters · filed 2019-03-15 | $334.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $211.00K derived: sum of 2 quarters · filed 2019-03-15 | $221.00K derived: sum of 3 quarters · filed 2019-03-15 | $234.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | $98.00K 10-Q · filed 2017-11-07 | $108.00K derived: sum of 2 quarters · filed 2017-11-07 | $121.00K 10-Q · filed 2017-11-07 | $143.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $10.00K 10-Q · filed 2017-08-11 | $23.00K 10-Q · filed 2017-08-11 | $45.00K derived: sum of 3 quarters · filed 2018-03-15 | $70.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $13.00K 10-Q · filed 2017-05-11 | $35.00K derived: sum of 2 quarters · filed 2018-03-15 | $60.00K derived: sum of 3 quarters · filed 2018-03-15 | $122.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $47.00K derived: sum of 2 quarters · filed 2018-03-15 | $109.00K derived: sum of 3 quarters · filed 2018-03-15 | $171.00K 10-K · filed 2018-03-15 |
| 2015-09-30 | $25.00K 10-Q · filed 2016-11-10 | $87.00K derived: sum of 2 quarters · filed 2016-11-10 | $149.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $62.00K 10-Q · filed 2016-08-09 | $124.00K 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | $111.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |